MedPath
HSA Approval

ORSERDU FILM-COATED TABLET 345 MG

SIN17096P

ORSERDU FILM-COATED TABLET 345 MG

ORSERDU FILM-COATED TABLET 345 MG

September 25, 2024

A. MENARINI SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantA. MENARINI SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L02BA04

Manufacturer Information

A. MENARINI SINGAPORE PTE. LTD.

CATALENT GREENVILLE, INC.

Active Ingredients

ELACESTRANT DIHYDROCHLORIDE eqv ELACESTRANT

345 MG

Elacestrant

Documents

Package Inserts

Orserdu film coated Tablet PI.pdf

Approved: September 25, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ORSERDU FILM-COATED TABLET 345 MG - HSA Approval | MedPath